Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

An mRNA-based flu shot could make a huge difference in flu prevention, allowing scientists to pick a better strain match.

Moderna mRNA flu vaccine beats standard shot, awaits FDA review

After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.

mRNA technology powers a better flu shot and what's behind those restless legs

A new mRNA flu vaccine, singing mice and doctors find what may be behind restless leg syndrome. Here are your health ...

Moderna stock surges on hantavirus vaccine, flu trial data

The company confirmed early-stage hantavirus research as a WHO-confirmed outbreak grows, while flu vaccine data published in ...
Hosted on MSN

Flu vaccine study finds equal protection for seniors

A large Kaiser Permanente-led study found no significant difference in protection between adjuvanted and high-dose flu vaccines for adults aged 65 and older during the 2023–24 season. The results ...